CSIMarket Company Name, Ticker, Suppliers, else..
 
Hoth Therapeutics Inc   (NASDAQ: HOTH)
 
Price: $0.8193 $0.82 %
Day's High: $0.8450000286102295 Week Perf: -13.83 %
Day's Low: $ 0.81 30 Day Perf: 15.67 %
Volume (M): 580,154 52 Wk High: $ 2.45
Volume (M$): $ 0 52 Wk Avg: $1.12
Open: $0.83 52 Wk Low: $0.49



 Market Capitalization (Millions $) 17
 Shares Outstanding (Millions) 21
 Employees 6
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Business Description


Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for dermatological conditions. They aim to address unmet medical needs in the field of dermatology using their proprietary technologies. The company's primary focus is on the development of therapeutics for patients suffering from skin diseases such as atopic dermatitis and psoriasis. Hoth Therapeutics Inc utilizes a combination of drug compounds and medical devices to provide potential solutions for these conditions. They are dedicated to improving the quality of life for patients and advancing the field of dermatology.


   Company Address: 720 Monroe Street Hoboken 7030 NJ
   Company Phone Number: 239-7459   Stock Exchange / Ticker: NASDAQ HOTH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARWR   -5%    
AXSM   -3.35%    
GOVX   -7.81%    
IONS   -2.71%    
SLN        1.81% 
TNXP        13.25% 
• View Complete Report
   



Stock Offering

Hoth Therapeutics' Exercise of Warrants Raises $4.2 Million, Fueling Innovation in Biopharmaceutical Space

Published Wed, Mar 27 2024 6:00 PM UTC

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
NEW YORK, March 27, 2024 - Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, recently made a significant announcement regarding the exercise of certain outstanding warrants. The company has entered into a definitive agreement to immediately exercise these w...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 2.05
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.7
Working Capital Ratio 6.41
Leverage Ratio (MRQ) 0.17
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.85 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0.38 $
Book Value 0.4 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,220,184
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.